Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial.
John B BuseHelene Nordahl ChristensenBrian J HartyJulie MitchellBenjamin P SouleEmily ZacherleMark CzirakyVincent J WilleyPublished in: BMJ open diabetes research & care (2023)